| Study title |
A Study of Benralizumab in Patients With Eosinophilic Esophagitis (MESSINA) |
| Disease or condition |
Eosinophilic Esophagitis |
| Study type |
Interventional (Clinical Trial) |
| Intervention/treatment |
Benralizumab or placebo |
| Phase |
3 |
| Study site |
University of North Carolina at Chapel Hill |
| Study location |
Chapel Hill |
| Principal investigator |
Evan Dellon, MD, MPH cedas@med.unc.edu |
| Study coordinator |
Kacie Walker, Kacie_Walker@med.unc.edu |
| Phone contact |
919-966-0139 |
| Clinicaltrials.gov link |
https://clinicaltrials.gov/ct2/show/NCT04543409 |
